← back to search

Weidong Zhao

Anhui Medical University · CN
Area of research
Obstetrics and Gynecology · Reproductive Medicine
Research interest
Research focused on Ovarian cancer and Bladder cancer, with related work in Cervical cancer, Oncology, Lymphadenectomy. Notable publications include 'AAV-ie enables safe and efficient gene transfer to inner ear cells', 'MiR-193a-3p promotes the multi-chemoresistance of bladder cancer by targeting the HOXC9 gene', and 'The miR-193a-3p regulated PSEN1 gene suppresses the multi-chemoresistance of bladder cancer'.
h-index
citations
442
works
17
NIH funding
primary concept
email

Recent publications

Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial
Nature Medicine 2024cited by 34position: middledoi
Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer
BMC Medicine 2024cited by 6position: middledoi
Fuzuloparib as maintenance therapy among patients with advanced ovarian cancer after a response to first-line platinum-based chemotherapy: Results from a randomized, placebo-controlled, phase III trial
Gynecologic Oncology 2024cited by 6position: middledoi
Anlotinib combined with penpulimab as first-line treatment for persistent, recurrent, or metastatic cervical cancer: Preliminary results from ALTER-GO-020, a single-arm, open-label, multi-cohort, multi-center phase II clinical study.
Journal of Clinical Oncology 2024cited by 2position: middledoi
Which factors predict parametrial involvement in stage IB cervical cancer? A Chinese multicentre study
European Journal of Surgical Oncology 2023cited by 4position: middledoi
Preoperative and intraoperative assessment of myometrial invasion in patients with FIGO stage I non-endometrioid endometrial carcinoma—a large-scale, multi-center, and retrospective study
Diagnostic Pathology 2023cited by 1position: middledoi
It is not the time to abandon intraoperative frozen section in endometrioid adenocarcinoma: A large‐scale, multi‐center, and retrospective study
Cancer Medicine 2023cited by 1position: middledoi
Comparison of surgical and radio-chemotherapy oncology outcomes for cervical adenocarcinoma FIGO2018 stage Ⅱ B
Research Square 2023cited by 0position: middledoi
Risk Factors and Prognosis of Early Recurrence in Stage I–II Endometrial Cancer: A Large-Scale, Multi-Center, and Retrospective Study
Frontiers in Medicine 2022cited by 15position: middledoi
Prognostic-Related Metabolic Score for Survival Prediction in Early-Stage Endometrioid Endometrial Cancer: A Multi-Center and Retrospective Study
Frontiers in Medicine 2022cited by 2position: middledoi
Comparison of oncology outcome between laparotomy and laparoscopy in early cervical squamous cell carcinoma without any high risk pathological factors
2022cited by 0position: middledoi
Implications of Isolated Para-Aortic Lymph Node Metastasis in Endometrial Cancer: A Large-Scale, Multicenter, and Retrospective Study
Frontiers in Medicine 2021cited by 21position: middledoi
Comparison of survival outcomes with or without Para-aortic lymphadenectomy in surgical patients with stage IB1-IIA2 cervical cancer in China from 2004 to 2016
BMC Cancer 2021cited by 11position: middledoi
L-MOCA: An open-label study of olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer.
Journal of Clinical Oncology 2021cited by 2position: middledoi
Comparison of Survival Outcomes with or Without Para-aortic Lymphadenectomy in Surgical Patients with Stage IB1-IIA2 Cervical Cancer in China from 2004-2016
Research Square 2021cited by 0position: middledoi
Impact of neoadjuvant chemotherapy on the postoperative pathology of locally advanced cervical squamous cell carcinomas: 1:1 propensity score matching analysis
European Journal of Surgical Oncology 2020cited by 3position: middledoi
AAV-ie enables safe and efficient gene transfer to inner ear cells
Nature Communications 2019cited by 227position: middledoi
<p>Impact of pelvic MRI in routine clinical practice on staging of IB1–IIA2 cervical cancer</p>
Cancer Management and Research 2019cited by 35position: middledoi
MiR-193a-3p promotes the multi-chemoresistance of bladder cancer by targeting the HOXC9 gene
Cancer Letters 2014cited by 63position: middledoi
The miR-193a-3p regulated PSEN1 gene suppresses the multi-chemoresistance of bladder cancer
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2014cited by 52position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Chunlin Chen · Dalian Medical University6 papers (2019–2023)Shan Kang · Qingdao University6 papers (2020–2023)Ping Liu · Ministry of Education of the People's Republic of China4 papers (2020–2023)Yan Ni · Xiamen University4 papers (2019–2021)Li Wang · Hebei Medical University4 papers (2021–2023)Ping Liu · Sichuan University3 papers (2019–2023)Jinghe Lang · Chinese Academy of Medical Sciences & Peking Union Medical College3 papers (2020–2023)Xiaolin Chen · Beijing Tian Tan Hospital3 papers (2021–2022)Donglin Li · Nanchang University3 papers (2020–2021)Lihong Lin · Wenzhou Medical University3 papers (2021–2023)Min Hao · Shanxi Medical University3 papers (2019–2023)Xiaonong Bin · Guangzhou Medical University3 papers (2021–2023)Cheng Zhang · Harbin Medical University2 papers (2014–2014)Qi Liu · Sun Yat-sen University Cancer Center2 papers (2014–2014)Jingde Zhu · Anhui Medical University2 papers (2014–2014)Zhumei Cui · Weifang Medical University2 papers (2022–2023)Daming Zhang · Shanxi Medical University2 papers (2014–2014)Hongwei Zhao · The First Affiliated Hospital, Sun Yat-sen University2 papers (2021–2021) · 2 papers (2019–2020)Jun Xiao · Anhui Medical University2 papers (2014–2014)